Fig. 1
From: Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?
Decision analysis model structure. A decision tree model structure; B markov model structure. SVR sustained virologic response, F0–F4 METAVIR fibrosis score, DC decompensated cirrhosis, HCC hepatocellular carcinoma, LT liver transplantation(first year), PLT post-liver transplantation (> 1 year), SOF Sofosbuvir, VEL Velpatasvir, LDV Ledipasivr, VOX Voxilaprevir, RBV ribavirin